Novostia Obtains EUR 2.5 Million Grant from the European Union To Support Its Heart Valve Technology
Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator.
The EIC Accelerator is part of the European Innovation Council (EIC) pilot that supports topclass companies with funding opportunities and acceleration services to help them develop and bring to market innovative products that have high potential to drive economic growth.
Novostia aims at improving the quality of life of people suffering from heart valve disease, especially children and young patients, providing them with a unique, durable, anticoagulant-free and silent heart valve prosthesis.
“This grant, together with our recent financing round of CHF 6.5 million, will accelerate the development of our technology toward the first in human studies. We appreciate the trust and support from the European Union, our investors, and partners and look forward to bringing this long-awaited innovation to patients and physicians” , said Geoffroy Lapeyre, Novostia CEO.
Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve. For more information, please visit www.novostia.com
Caution: Novostia technology is an investigational device not yet approved for sale.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-GILEAD-SCIENCES,-INC.21.1.2020 23:32:09 CET | Press release
Gilead Sciences to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 4, 2020
BERMUDA-BUSINESS-DEVLPMT21.1.2020 23:12:09 CET | Press release
Bermuda Further Enhances Its International Appeal as Incorporated Segregated Accounts Companies Legislation Comes Into Effect
NASPERS-LIMITED21.1.2020 18:35:04 CET | Press release
Naspers Limited Launches the Sale of c. 22 Million N Ordinary Shares of Prosus N.V. Through an Accelerated Bookbuild Offering to Institutional Investors
NV-RIMINI-STREET21.1.2020 15:02:08 CET | Press release
Hearing Australia Shifts its E-Business Support and Maintenance to Rimini Street
CA-SD-ASSOCIATION21.1.2020 14:57:07 CET | Press release
SD & microSD Memory Cards - the World’s First Choice in Memory Cards - 20 Years of Innovation
WI-SHINE-MEDICAL21.1.2020 14:47:07 CET | Press release
SHINE and IOCB Prague deliver patient dose quantities of lutetium-177 to GE Healthcare, advance therapeutic isotope toward commercialization
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom